• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Harpoon Therapeutics Inc.

    3/12/24 12:15:11 AM ET
    $HARP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $HARP alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: March 11, 2024
    Accession Number: 0001193125-24-064463
    Submission Type: POS AM
    CIK: 0001708493
    Company Name: Harpoon Therapeutics, Inc.
    File Number: 333-272064
    Get the next $HARP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HARP

    DatePrice TargetRatingAnalyst
    1/5/2024$23.00Outperform
    Oppenheimer
    11/20/2023Outperform
    TD Cowen
    7/6/2022$16.00Buy
    Canaccord Genuity
    11/11/2021$25.00 → $19.00Outperform
    SVB Leerink
    9/28/2021$16.00Neutral → Buy
    Citigroup
    8/6/2021$29.00 → $25.00Outperform
    SVB Leerink
    More analyst ratings